Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer [Phase 1, Phase 2]
A Phase 1/2 study of TC-510 from TCR2 Therapeutics in mesothelin-expressing cancers is active but not recruiting, spanning multiple indicati…
-
CLINICAL_TRIALS trial_result · 2025-08-27Clinical Trial Update: Blood Flow Restriction Exercise in Patients With Pancreatic, Biliary Tract, and Liver Cancer (PREV-Ex) [NA]
ClinicalTrials.gov update reports that the PREV-Ex trial evaluating blood flow restriction exercise in patients with pancreatic cancer, bili…
-
CLINICAL_TRIALS trial_result · 2025-08-26Clinical Trial Update: Enhanced Assistance During Radiotherapy for Unmet Essential Needs [NA]
A completed clinical trial evaluated enhanced assistance during radiotherapy to address unmet essential needs across multiple cancer types.
-
CLINICAL_TRIALS other · 2025-08-26Clinical Trial Update: HRS-4642 in Combination With AG for Neoadjuvant and Adjuvant Treatment of Pancreatic Cancer [Phase 2]
Phase 2 clinical trial update shows that HRS-4642 in combination with AG for neoadjuvant and adjuvant treatment of pancreatic cancer is curr…
-
CLINICAL_TRIALS research · 2025-08-24Clinical Trial Update: EUS- and US- Guided Biopsy for Pancreatic Lesion
A clinical trial update for a study evaluating endoscopic ultrasound- and ultrasound-guided biopsy of pancreatic lesions to diagnose pancrea…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS other · 2025-08-24Clinical Trial Update: A Study Comparing MRG004A Plus Best Supportive Care Versus Placebo and Best Supportive Care in the Treatment of Patients With Advanced Pancreatic Cancer [Phase 3]
A Phase 3 trial evaluating MRG004A plus best supportive care versus placebo plus best supportive care in advanced pancreatic cancer is curre…
-
CLINICAL_TRIALS trial_result · 2025-08-22Clinical Trial Update: Siltuximab and Spartalizumab in Patients With Metastatic Pancreatic Cancer [Phase 1, Phase 2]
Clinical trial update reporting completed Phase 1/2 evaluation of combining siltuximab and spartalizumab in metastatic pancreatic cancer; re…
-
CLINICAL_TRIALS trial_result · 2025-08-21Clinical Trial Update: A Phase I Clinical Study of Intratumoral Injection Oncolytic Vaccinia Virus GC001 in Patient With Advanced Solid Tumors [Phase 1]
A Phase I trial evaluating intratumoral injection of GC001, an oncolytic vaccinia virus, in patients with advanced solid tumors is currently…
-
CLINICAL_TRIALS research · 2025-08-21Clinical Trial Update: Micro-Tech FNB Needle to Obtain Tissue Specimens of Pancreas Malignancy for Personalized Based Chemotherapy
A clinical trial is evaluating the Micro-Tech fine-needle biopsy needle to obtain tissue from pancreatic malignancies to guide personalized …
-
CLINICAL_TRIALS trial_result · 2025-08-20Clinical Trial Update: Glycan Mediated Immune Regulation With a Bi-Sialidase Fusion Protein (GLIMMER-01) [Phase 1, Phase 2]
Phase 1/2 trial results for GLIMMER-01, a bi-sialidase fusion protein from Palleon, tested across multiple solid tumors with results posted …
-
CLINICAL_TRIALS other · 2025-08-17Clinical Trial Update: A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Resectable Pancreatic Cancer [Phase 1, Phase 2]
An ongoing single-arm, open-label Phase 1/2 clinical trial evaluating VRT106 in combination with chemotherapy for resectable pancreatic canc…
-
CLINICAL_TRIALS research · 2025-08-15Clinical Trial Update: A Multicenter Study of IBI343 Monotherapy Versus Placebo in Subjects With Previously Treated, Claudin (CLDN) 18.2-positive, Pancreatic Cancer(G-HOPE-002) [Phase 3]
A Phase 3 multicenter trial comparing IBI343 monotherapy to placebo in previously treated CLDN18.2-positive pancreatic cancer is currently r…
-
CLINICAL_TRIALS research · 2025-08-15Clinical Trial Update: Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors [Phase 1]
Phase 1 study evaluating safety and tolerability of BCA101 as monotherapy and in combination in EGFR-driven advanced solid tumors. The trial…
-
CLINICAL_TRIALS trial_result · 2025-08-14Clinical Trial Update: 'OLAP' (OLAparib Regulatory Post-marketing Surveillance)
A post-marketing surveillance trial of olaparib (Lynparza) conducted by AstraZeneca has completed, reporting safety monitoring results acros…
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Early Treatment ctDNA Dynamics to Predict Response to Chemotherapy
Clinical trial update examining early ctDNA dynamics to predict response to chemotherapy in metastatic pancreatic cancer.
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Pan-tumor MRD Study
Paradigm Health's Pan-tumor MRD study (NCT06605404) is currently recruiting across several solid tumor indications including bladder, esopha…
-
CLINICAL_TRIALS trial_result · 2025-08-14Clinical Trial Update: Tovorafenib (DAY101) or in Combination With Pimasertib for Participants With Melanoma and Other Solid Tumors [Phase 1]
A Phase 1 trial evaluating tovorafenib (DAY101) alone or with pimasertib for melanoma and other solid tumors has been terminated.
-
EMA approval · 2025-08-12EMA Authorised: Naveruclif (paclitaxel) — Accord Healthcare S.L.U.
EMA authorised Naveruclif (paclitaxel) by Accord Healthcare S.L.U. for breast cancer, pancreatic cancer, and non-small cell lung cancer.
-
CLINICAL_TRIALS research · 2025-08-12Clinical Trial Update: Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events [NA]
A clinical trial at MD Anderson Cancer Center is evaluating enhanced outpatient symptom management to reduce acute care visits caused by che…
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: 64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating 64Cu-LNTH-1363S in patients with metastatic sarcoma and GI tract cancers (esophageal, gastric, pancrea…
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: The Purpose of This Study is to Evaluate the Safety, Tolerability and Efficacy of TMT101 Injection Monotherapy in Patients With Advanced Pancreatic Cancer or Non-small Cell Lung Cancer(NSCLC) [Phase 1]
Phase 1 study to evaluate the safety, tolerability, and efficacy of TMT101 injection as monotherapy in patients with advanced pancreatic can…
-
CLINICAL_TRIALS trial_result · 2025-08-11Clinical Trial Update: A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours [Phase 1, Phase 2]
Cancer Research UK reported an ongoing Phase 1/2a trial of HMBD-001 in HER3-positive solid tumors; the study is currently Active Not Recruit…
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: Improving a Bile Duct Drainage Procedure in Patients With Inoperable Cancer Blocking the Bile Ducts: Comparing Two Types of Endoscopically Placed Internal Stents to Prevent Blockage of a Lumen Apposing Metal Stent [NA]
A clinical trial update describes a study comparing two endoscopically placed internal stents to prevent blockage of a lumen-apposing metal …
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: XH001 (New Antigen Tumor Vaccine) Combined With Chemotherapy as Adjuvant Therapy in Pancreatic Cancer [NA]
This clinical trial update reports XH001, a new antigen tumor vaccine, being studied with chemotherapy as adjuvant therapy for pancreatic ca…
-
CLINICAL_TRIALS research · 2025-08-08Clinical Trial Update: Stereotactic Body Radiation Therapy for Inoperable Non-metastasized Pancreatic Adenocarcinoma [NA]
A clinical trial is evaluating stereotactic body radiation therapy for patients with non-metastasized unresectable pancreatic adenocarcinoma…